nanoll
extt
Contact admin for Full-Text
Please use this identifier to cite or link to this item:
http://lrcdrs.bennett.edu.in:80/handle/123456789/425Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Nilanjan, Banik, | - |
| dc.date.accessioned | 2023-03-23T12:38:27Z | - |
| dc.date.available | 2023-03-23T12:38:27Z | - |
| dc.date.issued | 2020-07 | - |
| dc.identifier.uri | http://lrcdrs.bennett.edu.in:80/handle/123456789/425 | - |
| dc.description.abstract | The Covid-19 pandemic has illustrated the importance of global trade for access to all kinds of medical supplies, with many jurisdictions suffering shortages of essential medical goods as a result of various trade barriers.1 Although no vaccine or truly effective therapeutic is yet available for the disease, when one does emerge its rapid distribution around the world will become an issue of the utmost international importance. Any trade barriers that needlessly delay the distribution of medicines and drive up their price should be identified and rejected. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Geneva Network | en_US |
| dc.subject | Covid-19 pandemic | en_US |
| dc.subject | Global trade | en_US |
| dc.title | Abolishing Pharmaceutical and Vaccine Tariffs to Promote Access | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Working Papers_SOM | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Abolishing_Pharmaceutical_and_Vaccine_Tariffs_to_Promote_Access.pdf Restricted Access | 1.36 MB | Adobe PDF | View/Open Request a copy |
Contact admin for Full-Text
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.